Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MESO
MESO logo

MESO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MESO News

Mesoblast Receives FDA BLA Filing Number for Rexlemestrocel-L

Jul 01 2026Newsfilter

Mesoblast Optimizes Capital Structure, Enhances Financial Flexibility

Jun 25 2026Newsfilter

Analysis of High Insider Ownership Growth Companies in Australia

May 31 2026Yahoo Finance

Conexeu Sciences Inc. Begins Trading on Nasdaq

May 22 2026PRnewswire

Conexeu Sciences Inc. Successfully Debuts on Nasdaq

May 22 2026Newsfilter

Mesoblast Reports Strong Q1 Sales for Ryoncil®

Apr 30 2026seekingalpha

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial

Apr 30 2026Newsfilter

Mesoblast Achieves Patient Recruitment Target in Chronic Low Back Pain Trial

Apr 30 2026Yahoo Finance

MESO Events

06/30 21:00
Mesoblast Submits Biologics License Application
Mesoblast announced that it has received a Biologics License Application filing number from the U.S. Food and Drug Administration and has requested a modular review of its BLA for rexlemestrocel-L in prevention of life-threatening gastrointestinal bleeding due to right ventricular dysfunction in end-stage heart failure patients with a left ventricular assist device. Rexlemestrocel-L has received Orphan Drug Designation for prevention of life-threatening major mucosal bleeding events and has Regenerative Medicine Advanced Therapy designation for this patient population, providing eligibility for rolling and priority reviews of the BLA. The new FDA leadership this past week provided additional guidance to how it approaches regulatory flexibility for products which address orphan rare diseases with high mortality and irreversible morbidity. The new draft guidance to industry titled 'Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products'1 highlights FDA's flexible approach to substantial evidence of effectiveness. This follows the May guidance from FDA titled 'Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application.'
06/11 09:00
Starfighters Space Borrow Rate Increases to 249.83%
Latest data shows the largest indicative borrow rate increases among liquid option names include: Starfighters Space, Inc. (FJET) 249.83% +3.74, Infosys (INFY) 54.04% +2.30, JBS Usa Holdings LLC (JBS) 2.90% +2.10, Merlin Inc (MRLN) 98.71% +1.79, Ares Capital (ARCC) 7.35% +1.71, ZenaTech Inc (ZENA) 14.62% +1.64, LASER PHOTONICS CORPORATION (LASE) 94.80% +0.93, Direxion S&P Biotech Bear 3X (LABD) 13.20% +0.69, Beyond Meat (BYND) 16.26% +0.65, and Mesoblast (MESO) 8.94% +0.60.
05/13 08:50
Significant Increases in Indicative Borrow Rates for Liquid Options
Latest data shows the largest indicative borrow rate increases among liquid option names include: T-REX 2X LONG MSTR DAILY TARGET (MSTU) 19.28% +1.44, Serve Robotics Inc (SERV) 26.46% +0.73, Defiance Daily Target 2x Long OKLO ETF (OKLL) 17.87% +0.73, Everspin Technologies (MRAM) 1.30% +0.72, Entravision (EVC) 1.96% +0.71, Direxion Daily Small Cap Bear 3X Shares (TZA) 6.50% +0.63, Rumble (RUM) 22.20% +0.60, Coursera (COUR) 0.90% +0.46, Xanadu Quantum Technologies Limited Class B (XNDU) 16.58% +0.37, and Mesoblast (MESO) 7.84% +0.32.

MESO Monitor News

No data

No data

MESO Earnings Analysis

No Data

No Data

People Also Watch